Filing Details
- Accession Number:
- 0001213900-19-024070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 16:18:18
- Reporting Period:
- 2019-11-19
- Accepted Time:
- 2019-11-19 16:18:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 812796 | Soligenix Inc. | SNGX | Pharmaceutical Preparations (2834) | 411505029 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1068029 | J Christopher Schaber | 29 Emmons Drive, Suite B-10 Princeton NJ 08540 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-19 | 10,770 | $0.93 | 53,095 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
